Literature DB >> 9261704

Improved burn scar assessment with use of a new scar-rating scale.

E K Yeong1, R Mann, L H Engrav, M Goldberg, V Cain, B Costa, M Moore, D Nakamura, J Lee.   

Abstract

The subjective assessment of scar appearance is a widely used method in the evaluation of burn outcomes and the efficacy of treatment methods. The purpose of this study is to design a numeric scar-rating scale with better interrater reliability than has previously been reported. The rating scale assesses scar surface, thickness, border height, and color differences between a scar and the adjacent normal skin. Eight raters were trained with use of a standardized set of photographs that provide examples of the scores to be assigned to each level of severity of each scar characteristic. The raters then rated 10 photographs of different scars, referring to the teaching set of pictures for comparison. The intraclass correlation (interrater reliability) was 0.94, 0.95, 0.90, and 0.85 for scar surface, border height, thickness, and color, respectively. This rating system has proved to be a useful tool for the evaluation of scar surface, thickness, border height, and color.

Mesh:

Year:  1997        PMID: 9261704     DOI: 10.1097/00004630-199707000-00014

Source DB:  PubMed          Journal:  J Burn Care Rehabil        ISSN: 0273-8481


  12 in total

1.  A polarized multispectral imaging system for quantitative assessment of hypertrophic scars.

Authors:  Pejhman Ghassemi; Taryn E Travis; Lauren T Moffatt; Jeffrey W Shupp; Jessica C Ramella-Roman
Journal:  Biomed Opt Express       Date:  2014-09-02       Impact factor: 3.732

2.  [Hyperplastic scars and keloids. Part I: basics and prevention].

Authors:  A Baisch; F Riedel
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

Review 3.  Hypertrophic scarring: the greatest unmet challenge after burn injury.

Authors:  Celeste C Finnerty; Marc G Jeschke; Ludwik K Branski; Juan P Barret; Peter Dziewulski; David N Herndon
Journal:  Lancet       Date:  2016-10-01       Impact factor: 79.321

4.  What score on the Vancouver Scar Scale constitutes a hypertrophic scar? Results from a survey of North American burn-care providers.

Authors:  Callie M Thompson; Ravi F Sood; Shari Honari; Gretchen J Carrougher; Nicole S Gibran
Journal:  Burns       Date:  2015-07-02       Impact factor: 2.744

5.  Cost-efficacy of cultured epidermal autografts in massive pediatric burns.

Authors:  J P Barret; S E Wolf; M H Desai; D N Herndon
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

6.  Reliable scar scoring system to assess photographs of burn patients.

Authors:  Gabriel A Mecott; Celeste C Finnerty; David N Herndon; Ahmed M Al-Mousawi; Ludwik K Branski; Sachin Hegde; Robert Kraft; Felicia N Williams; Susana A Maldonado; Haidy G Rivero; Noe Rodriguez-Escobar; Marc G Jeschke
Journal:  J Surg Res       Date:  2014-11-06       Impact factor: 2.192

7.  Combination of W-plasty and Botulinum Neurotoxin Type A Injection for Preventing Rhytidectomy Scar in Asians.

Authors:  Chung-Hee Han
Journal:  Aesthetic Plast Surg       Date:  2022-06-13       Impact factor: 2.326

8.  Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens.

Authors:  Gisele V Oliveira; Hal K Hawkins; David Chinkes; Ann Burke; Andre Luiz Pasqua Tavares; Marcia Ramos-e-Silva; Thomas B Albrecht; Gregory T Kitten; David N Herndon
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

9.  Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children.

Authors:  Ludwik K Branski; David N Herndon; Robert E Barrow; Gabriela A Kulp; Gordon L Klein; Oscar E Suman; Rene Przkora; Walter Meyer; Ted Huang; Jong O Lee; David L Chinkes; Ronald P Mlcak; Marc G Jeschke
Journal:  Ann Surg       Date:  2009-10       Impact factor: 12.969

Review 10.  Recombinant human growth hormone for treating burns and donor sites.

Authors:  Roelf S Breederveld; Wim E Tuinebreijer
Journal:  Cochrane Database Syst Rev       Date:  2014-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.